Disproportionality analysis of psychiatric morbidities associated with isotretinoin using VigiBase
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03293-6 ↗Kurz gefasst
Leserbrief in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Eric Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Isotretinoin, Acne Vulgaris, Dermatologic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
- Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
- University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Harvard Medical School, Boston, MA, USA.
- Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
- Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. amostaghimi@bwh.harvard.edu.
Zitieren
APA
Xia, E., Manjaly, P., Ly, S., Kamal, K., Theodosakis, N., & Mostaghimi, A. (2024). Disproportionality analysis of psychiatric morbidities associated with isotretinoin using VigiBase. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03293-6
Vancouver
Xia E, Manjaly P, Ly S, Kamal K, Theodosakis N, Mostaghimi A. Disproportionality analysis of psychiatric morbidities associated with isotretinoin using VigiBase. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03293-6
BibTeX
@article{Xia2024,
author = {Xia, Eric and Manjaly, Priya and Ly, Sophia and Kamal, Kanika and Theodosakis, Nicholas and Mostaghimi, Arash},
title = {Disproportionality analysis of psychiatric morbidities associated with isotretinoin using VigiBase},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03293-6}
}
EUVIMED